THE recent work of de Jong and Baruk on the experimental production of catatonia in animals by means of bulbocapnine throws light on the condition of catalepsy. The first important fact discovered is that bulbocapnine can produce effects in the higher animals corresponding to those of catalepsy in man, but cannot produce such effects in the lower vertebrates (frogs, snakes, lizards, fish), which lack a neocortex. Furthermore, as stated by de Jong and Baruk, in an animal whose cortex has been removed. bulbocapnine does not cause catalepsy. This indicates that the catalepsyproducing effect of bulbocapnine occurs through a specific action of the drug on the cerebral cortex. In fowls, which have but a rudimentary neocortex, the catalepsy is incomplete and unstable. In moderate doses bulbocapnine has the unique effect of producing catalepsy. What is the physiological process at work here'?
We must assume that in catalepsy there is primarily-a blocking of sensory nerve-impulses in the central nervous system. That this is so is indicated by the fact that one may stick a pin into to inhibition-of other parts of the central nervous system. It is to be noted that in animals lacking a neocortex (fish and reptiles), signs of hyperkinesis-of rapid and mechanical-like movements-are caused by bulbocapnine (large doses). May it not be that in these lower animals bulbocapnine has a selective action on the sensory elements of the brain, as in the higher animals ? On account of the absence of a neocortex catalepsy is not produced. But why do we get the movements of hyperkinesis? Surely because the proprioceptive sensory impulses would be interfered with in a selective action of the drug on the sensory elements of such a brain. In the brain of the higher animals, a special organ, the neocortex, exists to deal in particular with stimuli from the external world.
Proprioceptive stimuli can be dealt with bv lower portions of the brain while the cortex is in a state of inhibition, as appears to be the case in catalepsy. In the lower animals, on the other hand. which lack a neocortex, all sensory impulses, including the proprioceptive, pass to a brain which cannot deal in a special area with impulses from external stimuli. Hence in such a brain a drug affecting these impulses from external stimuli would also be likely to affect the more closely intermingled proprioceptive impulses, thus throwing the muscular system out of equilibrium, and resulting in movement.
In the catalepsy of the higher animals, where only the cortex appears to be affected and proprioceptive impulses are not interfered with, a motionless state results, the muscular system not being thrown out of equilibrium. But when larger doses of the drug are given its effect extends to subcortical areas of the brain-still selecting the sensory elements, so that proprioceptive centres are interfered with, the subcortical motor centres no longer receive complete information, as it were, about the rosition el different parts of the body, and so exhibit disordered activity in purposeless, mechanical movements, or sudden violent efforts. This at least seems to be a possible interpretation of the action of bulbocapnine as suggested by the experimental work of de Jong and Baruk.
The fact that bulbocapnine in still larger doses causes convulsions (' epilepsy ') does not recessarily belie these conclusions, for many different kinds of drugs in large enough doses can produce convulsions, through a disorganisation of the nervous system and of the body generally.
